Joined Today: 0

ALNY Alnylam Pharmaceuticals, Stock Message Board

All Messages

ALNY Message Board Home | Join The ALNY Group |

#76: ALNY News Alnylam Announces Closing of Common Stock Offering
Stock News Bot	December 15, 2006 01:01:00 PM
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY) announced today the closing of its public offering of 4,700,000 shares of common stock. Net proceeds to... view message ignore post recommend post

#75: ALNY News Alnylam Announces Proceeds of Common Stock Offering
Stock News Bot	December 12, 2006 01:01:00 PM
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY) announced today that the net proceeds to the company from its offering of 4,700,000 shares of common... view message ignore post recommend post

#74: ALNY News Alnylam Announces Public Offering of 4,700,000 Shares of Common Stock
Stock News Bot	December 11, 2006 01:36:00 PM
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY) announced today its intention to offer and sell approximately 4,700,000 shares of common stock in a... view message ignore post recommend post

#73: ALNY News Alnylam Advances a Systemically Delivered RNAi Therapeutic Targeting PCSK9 for the Treatment of Hypercholesterolemia as New Development Program
Stock News Bot	December 5, 2006 05:00:00 AM
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, announced today that it will advance a systemically delivered... view message ignore post recommend post

#72: ALNY News Alnylam to Webcast its R&D Day on Tuesday, December 5, 2006
Stock News Bot	November 29, 2006 05:00:00 AM
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced that its R&D Day presentation will be webcast... view message ignore post recommend post

#71: ALNY News Alnylam Initiates Clinical Program to Evaluate Anti-Viral Activity for ALN-RSV01, an RNAi Therapeutic for the Treatment of Respiratory Syncytial Virus (RSV) Infection
Stock News Bot	November 28, 2006 05:00:00 AM
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, announced today that it has initiated a human experimental... view message ignore post recommend post

#70: ALNY News Isis and Alnylam Announce Issued U.S. Patent Broadly Covering Chemical Modifications of Oligonucleotide Therapeutics
Stock News Bot	November 27, 2006 05:00:00 AM
CARLSBAD, Calif. & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Isis Pharmaceuticals, Inc. (Nasdaq: ISIS) and Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY) announced today that a key patent was... view message ignore post recommend post

#69: ALNY News Alnylam to Webcast Presentation at the 2006 Piper Jaffray Health Care Conference
Stock News Bot	November 21, 2006 01:00:00 PM
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced that management will present a company overview... view message ignore post recommend post

#68: ALNY News Alnylam to Webcast Presentation at the 2006 Bear Stearns SMid-Cap Investor Conference
Stock News Bot	November 10, 2006 01:00:00 PM
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced that management will present a company overview... view message ignore post recommend post

#67: ALNY News Alnylam and Yale University Scientists Demonstrate Therapeutic Silencing of Disease Target Associated with Acute Lung Injury Using RNAi
Stock News Bot	November 6, 2006 05:00:00 AM
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, announced today publication of data demonstrating that an RNAi... view message ignore post recommend post

#66: ALNY News Alnylam Pharmaceuticals Reports Third Quarter 2006 Financial Results
Stock News Bot	November 2, 2006 01:01:00 PM
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today reported its consolidated financial results for the quarter... view message ignore post recommend post

#65: ALNY News Alnylam to Webcast Presentation at Upcoming Investor Conferences
Stock News Bot	October 31, 2006 01:01:00 PM
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced that management will present a company overview... view message ignore post recommend post

#64: ALNY News Alnylam to Webcast Conference Call Discussing Third Quarter 2006 Financial Results
Stock News Bot	October 26, 2006 01:01:00 PM
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced that it will report financial results for the... view message ignore post recommend post

#63: ALNY News Alnylam to Webcast Presentation at the 2006 C.E. Unterberg, Towbin Life Sciences Conference
Stock News Bot	October 23, 2006 01:01:00 PM
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced that management will present a company overview... view message ignore post recommend post

#62: ALNY News Alnylam Announces Progress in Pre-Clinical Hypercholesterolemia RNAi Therapeutic and microRNA Programs
Stock News Bot	October 23, 2006 05:00:00 AM
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, announced today that it presented pre-clinical data at the 2nd... view message ignore post recommend post

Group Home | Login if you want to post a message